Close
Close
Treatment Database
mRNA encoding human argininosuccinate lyase
Trade Name not avaiable
Orphan Indication Argininosuccinate lyase deficiency
USA Market Approval
USA Designation Date 18-09-2017
Sponsor PhaseRx, Inc.
410 West Harrison Street, Suite 300
Seattle, Washington, 98119
More about Argininosuccinic Aciduria
Free Newsletter
Treatment News
Videos
by Abidemi Uruejoma
4 views
by Abidemi Uruejoma
14 views
by Abidemi Uruejoma
14 views
by Abidemi Uruejoma
44 views
by Abidemi Uruejoma
59 views